{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:23:19Z","timestamp":1787743399856,"version":"build-2784847793"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>\n                      To evaluate the cost effectiveness of universal fetal echocardiogram for patients with pregestational diabetes mellitus by first-trimester hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      (Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      ) level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We developed a cost-effectiveness model comparing two strategies of screening for critical fetal congenital heart disease among patients with diabetes: universal fetal echocardiogram and fetal echocardiogram only after abnormal findings on detailed anatomy ultrasonogram. We excluded ventricular septal defect, atrial septal defects, and bicuspid aortic valve from the definition of critical fetal congenital heart disease. Probabilities and costs were derived from the literature. We used individual models to evaluate different scenarios: first-trimester Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      lower than 6.5%, Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      6.5\u20139.0%, and Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      higher than 9.0%. Primary outcomes included fetal death, neonatal death, and false-positive and false-negative results. A cost-effectiveness threshold was set at $100,000 per quality-adjusted life-year. Univariable sensitivity analyses were performed to investigate the drivers of the model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Universal fetal echocardiogram is not cost effective except for when first-trimester Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      level is higher than 9.0% (incremental cost-effectiveness ratio $638,100, $223,693, and $67,697 for Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      lower than 6.5%, 6.5\u20139.0%, and higher than 9.0%, respectively). The models are sensitive to changes in the probability of congenital heart disease at a given Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      level, as well as the cost of neonatal transfer to a higher level of care. Universal fetal echocardiogram became both cost saving and more effective when the probability of congenital heart disease reached 14.48% (15.4 times the baseline risk). In the Monte Carlo simulation, universal fetal echocardiogram is cost effective in 22.7%, 48.6%, and 62.3% of scenarios for each of the three models, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>\n                      For pregnant patients with first-trimester Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      levels lower than 6.5%, universal fetal echocardiogram was not cost effective, whereas, for those with first-trimester Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      levels higher than 9.0%, universal fetal echocardiogram was cost effective. For those with intermediate Hb A\n                      <jats:sub>1c<\/jats:sub>\n                      levels, universal fetal echocardiogram was cost effective in about 50% of cases; therefore, clinical judgment based on individual patient values, willingness to pay to detect congenital heart disease, and resource availability needs to be considered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005538","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:02:26Z","timestamp":1709226146000},"page":"715-724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Universal Fetal Echocardiography for Pregestational Diabetes Mellitus"],"prefix":"10.1097","volume":"144","author":[{"given":"Leah M.","family":"Savitsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sterrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Olerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"R1-20260826","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00125-012-2455-y","article-title":"Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study","volume":"55","author":"Bell","year":"2012","journal-title":"Diabetologia"},{"key":"R2-20260826","doi-asserted-by":"crossref","first-page":"k2638","DOI":"10.1136\/bmj.k2638","article-title":"Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden","volume":"362","author":"Ludvigsson","year":"2018","journal-title":"BMJ"},{"key":"R3-20260826","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2337\/dc07-0278","article-title":"Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes","volume":"30","author":"Guerin","year":"2007","journal-title":"Diabetes Care"},{"key":"R4-20260826","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s001250050010","article-title":"Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus","volume":"43","author":"Suhonen","year":"2000","journal-title":"Diabetologia"},{"key":"R5-20260826","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamacardio.2018.2009","article-title":"Live-born major congenital heart disease in Denmark: incidence, detection rate, and termination of pregnancy rate from 1996 to 2013","volume":"3","author":"Lytzen","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R6-20260826","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1469-0705.1999.14040225.x","article-title":"Prenatal screening of congenital heart disease between ethics and cost-effectiveness: time for a change in current prenatal ultrasound screening policies?","volume":"14","author":"Paladini","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R7-20260826","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.113.003711","article-title":"Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome","volume":"129","author":"Morris","year":"2014","journal-title":"Circulation"},{"key":"R8-20260826","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.08.063","article-title":"Society for Maternal-Fetal Medicine special statement: updated checklist for antepartum care of pregestational diabetes mellitus","volume":"223","author":"Hameed","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R9-20260826","first-page":"S183","article-title":"14: Management of diabetes in pregnancy: Standards of Medical Care in Diabetes\u20132020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"R10-20260826","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.7863\/jum.2013.32.6.1083","article-title":"AIUM practice guideline for the performance of obstetric ultrasound examinations","volume":"32","year":"2013","journal-title":"J Ultrasound Med"},{"key":"R11-20260826","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/uog.12403","article-title":"ISUOG practice guidelines (updated): sonographic screening examination of the fetal heart","volume":"41","author":"Carvalho","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20260826","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/2047487314551547","article-title":"Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis","volume":"22","author":"Liu","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R13-20260826","doi-asserted-by":"crossref","first-page":"e65484","DOI":"10.1371\/journal.pone.0065484","article-title":"Performance of different scan protocols of fetal echocardiography in the diagnosis of fetal congenital heart disease: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R14-20260826","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ije\/dyz009","article-title":"Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies","volume":"48","author":"Liu","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R15-20260826","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.289.6441.345","article-title":"Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy","volume":"289","author":"Ylinen","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R16-20260826","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pd.1322","article-title":"Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies","volume":"26","author":"Odibo","year":"2006","journal-title":"Prenat Diagn"},{"key":"R17-20260826","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00246-013-0704-6","article-title":"Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus","volume":"34","author":"Starikov","year":"2013","journal-title":"Pediatr Cardiol"},{"key":"R18-20260826","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/jum.15163","article-title":"AIUM practice parameter for the performance of detailed second- and third-trimester diagnostic obstetric ultrasound examinations","volume":"38","year":"2019","journal-title":"J Ultrasound Med"},{"key":"R19-20260826","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/uog.13287","article-title":"Cost-effectiveness of prenatal screening strategies for congenital heart disease","volume":"44","author":"Pinto","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R20-20260826","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpeds.2009.01.050","article-title":"Prenatal detection of congenital heart disease","volume":"155","author":"Friedberg","year":"2009","journal-title":"J Pediatr"},{"key":"R21-20260826","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pd.4755","article-title":"Intrauterine fetal demise after prenatal diagnosis of congenital heart disease: assessment of risk","volume":"36","author":"Divanovic","year":"2016","journal-title":"Prenat Diagn"},{"key":"R22-20260826","first-page":"1","article-title":"Fetal and perinatal mortality, United States, 2006","volume":"60","author":"MacDorman","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"R23-20260826","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/jama.2011.1798","article-title":"Association between stillbirth and risk factors known at pregnancy confirmation","volume":"306","year":"2011","journal-title":"JAMA"},{"key":"R24-20260826","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/ijerph17093056","article-title":"Children born with congenital heart defects and growth restriction at birth: a systematic review and meta-analysis","volume":"17","author":"Ghanchi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R25-20260826","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"Pregestational diabetes mellitus. ACOG Practice Bulletin No. 201. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R26-20260826","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/uog.14882","article-title":"Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis","volume":"45","author":"Holland","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20260826","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpeds.2009.01.040","article-title":"Improving decision analyses: parent preferences (utility values) for pediatric health outcomes","volume":"155","author":"Carroll","year":"2009","journal-title":"J Pediatr"},{"key":"R28-20260826","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2014.11.015","article-title":"Grief after second-trimester termination for fetal anomaly: a qualitative study","volume":"91","author":"Maguire","year":"2015","journal-title":"Contraception"},{"key":"R29-20260826","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V","article-title":"Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most","volume":"19","author":"Kuppermann","year":"1999","journal-title":"Prenat Diagn"},{"key":"R30-20260826","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pd.494","article-title":"Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?","volume":"22","author":"Grobman","year":"2002","journal-title":"Prenat Diagn"},{"key":"R31-20260826","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00737-008-0040-7","article-title":"Long-term psychosocial sequelae of stillbirth: phase II of a nested case-control cohort study","volume":"12","author":"Turton","year":"2009","journal-title":"Arch Womens Ment Health"},{"key":"R32-20260826","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2393-12-43","article-title":"Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study","volume":"12","author":"Gravensteen","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"R33-20260826","first-page":"511","article-title":"Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences","volume":"96","author":"Kuppermann","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R34-20260826","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2337\/db11-1625","article-title":"Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort","volume":"61","author":"Miller","year":"2012","journal-title":"Diabetes"},{"key":"R35-20260826","first-page":"1","article-title":"Births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"R36-20260826","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R37-20260826","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/uog.21977","article-title":"Detection of fetal cardiac anomalies: cost-effectiveness of increased number of cardiac views.","volume":"55","author":"Bak","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R38-20260826","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1055\/s-0039-1685490","article-title":"The accuracy and cost-effectiveness of selective fetal echocardiography for the diagnosis of congenital heart disease in patients with pregestational diabetes stratified by hemoglobin A1c","volume":"36","author":"Finneran","year":"2019","journal-title":"Am J Perinatol"},{"key":"R39-20260826","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/chd.12632","article-title":"Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease","volume":"13","author":"Brosig","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"R40-20260826","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIR.0b013e318265ee8a","article-title":"Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association","volume":"126","author":"Marino","year":"2012","journal-title":"Circulation"},{"key":"R41-20260826","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12955-019-1265-z","article-title":"Quality of life in children with infrequent congenital heart defects: cohort study with one-year of follow-up","volume":"18","author":"Moreno-Medina","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"R42-20260826","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1067\/mob.2001.109735","article-title":"Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies","volume":"184","author":"Smith","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R44-20260826","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0038-1676495","article-title":"Cytomegalovirus screening in pregnancy: a cost-effectiveness and threshold analysis","volume":"36","author":"Albright","year":"2019","journal-title":"Am J Perinatol"},{"key":"R45-20260826","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s10995-012-1203-8","article-title":"Hospital costs associated with stillbirth delivery","volume":"17","author":"Gold","year":"2013","journal-title":"Matern Child Health J"},{"key":"R46-20260826","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.earlhumdev.2006.01.001","article-title":"Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants","volume":"82","author":"Phibbs","year":"2006","journal-title":"Early Hum Dev"},{"key":"R47-20260826","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.amjcard.2011.07.052","article-title":"Costs of prenatal detection of congenital heart disease","volume":"108","author":"Jegatheeswaran","year":"2011","journal-title":"Am J Cardiol"},{"key":"R49-20260826","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/109065702760093906","article-title":"Health-related quality-of-life assessment of prenatal diagnosis: chorionic villi sampling and amniocentesis","volume":"6","author":"Feeny","year":"2002","journal-title":"Genet Test"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:00:30Z","timestamp":1787742030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005538"}},"subtitle":["A Cost-Effectiveness Analysis"],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005538","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"2023-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}